Long Grove Pharmaceuticals - Ownership and Business Overview

Life ScienceCompany

Long Grove Pharmaceuticals Ownership

Who owns Long Grove Pharmaceuticals?

Long Grove Pharmaceuticals is owned by Water Street Healthcare Partners. It was acquired on January 1, 2019.

Is Long Grove Pharmaceuticals PE-backed?

Yes. Long Grove Pharmaceuticals is owned by private equity investor Water Street Healthcare Partners.

Long Grove Pharmaceuticals Business Overview

Where is Long Grove Pharmaceuticals headquartered?

Long Grove Pharmaceuticals is headquartered in Rosemont, Illinois.

What sector is Long Grove Pharmaceuticals in?

Long Grove Pharmaceuticals is a life science company.

When was Long Grove Pharmaceuticals founded?

Long Grove Pharmaceuticals was founded in 2019.

Life Science M&A Summary in 2019

Out of 60 sectors in the Mergr database, life science ranked 9 in number of deals in 2019. The largest life science acquisition in 2019 was Celgene - which was acquired by Bristol-Myers Squibb for $74.0B.

Join Mergr to view all 251 acquisitions of life science companies in 2019, including 44 acquisitions by private equity firms, and 207 by strategics.

Long Grove Pharmaceuticals

Long Grove Pharmaceuticals LLC

9450 W Bryn Mawr Ave., Suite 200,
Rosemont, Illinois 60018
United States,
www.longgrovepharma.com

Long Grove Pharmaceuticals is a specialty pharmaceutical company focused on complex generics including injectables and topical products. Long Grove stands out for its strength in addressing generic development opportunities with complex formulations, challenging manufacturing and supply chain dynamics, and uncommon regulatory approval pathways in niche markets. Long Grove Pharmaceuticals was founded in 2019 and is based in Rosemont, Illinois.


 Subscribe to unlock this and 208,602
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 201K M&A Transactions
  • 204K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.